Live30 webinars are thirty minute presentations designed to update you on the latest innovations, applications and data in a fast yet interactive format.
The Advanced Therapy Treatment Centres (ATTC) network program - coordinated by the UK’s Cell and Gene Therapy Catapult (CGT Catapult) - addresses the complex challenges of bringing pioneering Advanced Therapy Medicinal Products (ATMPs) to patients. The ATTC networks look at standardizing cryogenic cold chain processes for cell therapies, with the aim to develop robust systems for the routine delivery of ATMPs throughout the UK’s NHS. Successful cryopreservation is a crucial step in manufacturing for effective clinical delivery. It also provides a commercially robust business model for ATMPs. The vital parameters to consider for successful cryopreservation include the:
This webinar takes a deep dive into the challenges of cryopreserving ATMP starting material and final therapy. Plus, we’ll discuss how a liquid nitrogen-free controlled rate freezer can help you achieve successful cryopreservation of different cellular therapy products.
Hear insights from industry leaders - including, Sandeep Kumar, Cell Therapy Advanced Specialist for NHSBT, UK and Dr. Julie Meneghel, Cytiva - about new research findings from the UK National Health Service Blood and Transplant (NHSBT).
After the webinar, join us for a live Q&A to discuss key considerations required to achieve optimal post-thaw outcomes and scalable, GMP-compliant cryopreservation.